CN Patent

CN101120006A — 蛋白酶体抑制剂及其使用方法

Assigned to Cephalon LLC · Expires 2008-02-06 · 18y expired

What this patent protects

本发明提供了可以通过例如抑制蛋白酶体活性来调节细胞凋亡的硼酸化合物、硼酸酯及其组合物。这些化合物和组合物可以用于诱导细胞凋亡和治疗疾病，例如癌症及其它直接或间接地与蛋白酶体活性相关的病症的方法。

USPTO Abstract

本发明提供了可以通过例如抑制蛋白酶体活性来调节细胞凋亡的硼酸化合物、硼酸酯及其组合物。这些化合物和组合物可以用于诱导细胞凋亡和治疗疾病，例如癌症及其它直接或间接地与蛋白酶体活性相关的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101120006A
Jurisdiction
CN
Classification
—
Expires
2008-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.